U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807190) titled 'General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus' on Jan. 29.
Brief Summary: The purpose of the study is to investigate the safety and effectiveness of Awiqli in participants with diabetes mellitus under real world clinical practice in Japan. Participants will get Awiqli as prescribed by the study doctor. The study will last for about 1 year.
Study Start Date: Feb. 01
Study Type: OBSERVATIONAL
Condition:
Diabetes Mellitus, Type 1
Intervention:
DRUG: Insulin Icodec
Participants will be treated with commercially available Awiqli according to routine clinical practice at the discretion of the treati...